lokonpharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Lokon Pharma | |
| Description | Lokon Pharma is a biotech company in the immune oncology space with immunostimulatory gene therapy as the main |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 194.169.225.47 |
| Location | Sweden |
Related Websites
| Site | Rank |
More to Explore
lokonpharma.com Valuation
|
US$329,594
Last updated: 2023-05-18 05:21:20
lokonpharma.com has Semrush global rank of 32,113,201. lokonpharma.com has an estimated worth of US$ 329,594, based on its estimated Ads revenue. lokonpharma.com receives approximately 38,031 unique visitors each day. Its web server is located in Sweden, with IP address 194.169.225.47. According to SiteAdvisor, lokonpharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$329,594 |
| Daily Ads Revenue | US$305 |
| Monthly Ads Revenue | US$9,128 |
| Yearly Ads Revenue | US$109,527 |
| Daily Unique Visitors | 2,536 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| lokonpharma.com. | A | 14400 | IP: 194.169.225.47 |
| lokonpharma.com. | NS | 21600 | NS Record: adns2.rackfish.net. |
| lokonpharma.com. | NS | 21600 | NS Record: adns1.rackfish.net. |
| lokonpharma.com. | MX | 14400 | MX Record: 10 lokonpharma-com.mail.protection.outlook.com. |
| lokonpharma.com. | TXT | 14400 | TXT Record: MS=ms37189004 |
| lokonpharma.com. | TXT | 14400 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-05-18 05:21:20
| Home Our Solution Pipeline For Patients News About Us Lokon Pharma Next generation cancer immunotherapeutics Our solution Read more Clinical trials LOKON001 Phase I/II study for pancreatic cancer Read more LOKON002 Phase I/II study for patients with pancreatic-, biliary-, ovarian-, and colorectal cancer Read more LOKON003 Phase I/II study for patients with malignant melanoma Read more Pipeline The LOAd family includes a range of novel oncolytic viruses with different immunostimulatory genes that are currently being evaluated for mechanisms-of-action (MOA) and proof-of-concept (POC). See our pipeline For patients If you live in the US and have pancreatic cancer or melanoma, you may be eligible for inclusion in our clinical trials LOKON001 or LOKON003. If you live in Sweden and have pancreatic cancer, melanoma, or ovarian cancer, you may be eligible for inclusion in our clinical trials LOKON002 or LOKON003. If you are interested to participate as a study patient in our trials, please, |
HTTP Headers
HTTP/1.1 200 OK Date: Thu, 26 May 2022 14:44:30 GMT Server: Apache Expires: Thu, 19 Nov 1981 08:52:00 GMT Cache-Control: no-store, no-cache, must-revalidate Pragma: no-cache Set-Cookie: PHPSESSID=7bae72660a11af023d7d372852854553; path=/ Upgrade: h2,h2c Connection: Upgrade Content-Type: text/html; charset=utf-8 |
lokonpharma.com Whois Information
Domain Name: LOKONPHARMA.COM Registry Domain ID: 1697722099_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.yoursrs.com Registrar URL: http://www.realtimeregister.com Updated Date: 2022-03-08T12:47:44Z Creation Date: 2012-01-19T10:42:29Z Registry Expiry Date: 2023-01-19T10:42:29Z Registrar: Realtime Register B.V. Registrar IANA ID: 839 Registrar Abuse Contact Email: rtr-security-threats@realtimeregister.com Registrar Abuse Contact Phone: +31.384530759 Domain Status: ok https://icann.org/epp#ok Name Server: ADNS1.RACKFISH.NET Name Server: ADNS2.RACKFISH.NET DNSSEC: unsigned >>> Last update of whois database: 2022-05-26T14:50:18Z <<< |